|
Market Closed -
Nasdaq
21:00:00 28/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.790 USD | -1.04% |
|
-8.89% | -21.53% |
| 09-20 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Global BMI Index | CI |
| 09-11 | Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.04% | -8.89% | -12.47% | -43.35% | -21.53% | +109.39% | +28.91% | -85.32% | -36.83% | 409M | |
| -0.37% | -3.67% | +2.80% | +36.91% | +78.51% | +57.21% | +87.75% | +7.17% | - | 72.26B | |
| -0.07% | -2.70% | -5.65% | +7.67% | +17.83% | +37.74% | +86.90% | +231.48% | +5,438.36% | 60.24B | |
| +0.47% | +1.71% | +9.64% | +51.79% | +70.32% | +35.23% | +17.31% | -57.43% | - | 27.73B | |
| -0.14% | -2.75% | -0.73% | +13.82% | -32.39% | -14.13% | +356.79% | +348.61% | +702.66% | 25.73B | |
| +0.57% | +1.10% | -2.93% | +8.62% | +4.08% | +1.02% | -2.89% | -64.17% | - | 24.75B | |
| +1.10% | +1.86% | +6.77% | +35.25% | +13.57% | +25.07% | -7.59% | -14.26% | +101.58% | 20.74B | |
| -1.70% | +0.43% | -25.24% | +10.93% | +172.60% | +150.24% | +323.16% | +1,349.34% | +609.13% | 15.06B | |
| +0.36% | +2.01% | +7.20% | +6.57% | +33.17% | +49.51% | +160.70% | +183.35% | +337.23% | 14.41B | |
| +2.59% | -4.94% | -6.28% | +6.98% | +18.82% | -5.97% | +508.36% | - | - | 14.23B | |
| -0.83% | -8.40% | +12.75% | +10.49% | -11.49% | -26.11% | +745.90% | +210.22% | +64.68% | 12.45B | |
| +0.09% | -0.94% | -3.13% | +0.86% | -11.21% | +21.88% | +240.85% | +533.39% | +4,100.16% | 11.93B | |
| +10.22% | +5.74% | +12.79% | +10.64% | -10.27% | -24.83% | +181.67% | +143.17% | - | 10.99B | |
| -0.70% | -4.84% | -22.91% | -17.02% | -1.40% | +99.57% | +143.07% | +7.93% | +829.83% | 9.31B | |
| +2.32% | -2.07% | -8.23% | -19.50% | +4.12% | +31.27% | +114.81% | +93.90% | +643.37% | 8.99B | |
| +0.95% | +0.83% | +5.84% | -2.18% | +330.30% | +235.43% | +432.50% | -14.80% | - | 8.95B | |
| +3.66% | -1.10% | -2.62% | +3.10% | +26.29% | +71.48% | +16.08% | +126.38% | - | 8.36B | |
| +1.54% | -9.39% | -10.90% | -9.79% | -0.14% | -35.80% | +78.41% | -25.72% | - | 8.06B | |
| +0.12% | -6.78% | -5.06% | -2.39% | +161.87% | +428.26% | +648.60% | -55.78% | -51.05% | 7.56B | |
| +1.70% | +3.82% | -6.78% | +13.39% | +1.77% | -1.25% | +171.35% | +265.99% | - | 6.99B | |
| Average | +0.99% | -1.39% | -2.76% | +6.14% | +42.24% | +62.26% | +216.63% | +167.55% | +1,158.10% | 18.46B | |
| Weighted average by Cap. | +0.54% | -1.35% | -0.98% | +16.62% | +42.33% | +46.09% | +169.83% | +159.24% | +2,272.87% |
- Stock Market
- Stocks
- RLMD Stock
- Sector Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
